Kaplan Fox Launches Securities Investigation Into The Ensign Group After Stock Drops 8% on Care Quality Report
Law firm Kaplan Fox & Kilsheimer LLP has initiated a securities law investigation into The Ensign Group, Inc. (NASDAQ: ENSG) following a critical report by Hunterbrook Media published in June 2026. The report alleged inadequate patient care and data manipulation, causing Ensign's stock to drop over 8%. Kaplan Fox is seeking investors who suffered losses to explore potential securities violations.
Ensign Group amends credit facility to $800 million By Investing.com
The Ensign Group Inc. (NASDAQ:ENSG) has amended its revolving credit facility, increasing it to $800 million and extending the maturity date to August 19, 2031. This new facility replaces the previous one and will be used to support acquisitions, capital investments, and general corporate purposes. Company executives highlighted that the amendment reflects confidence in their operating model and financial strength, providing liquidity for future investments in healthcare operations and real estate.
Kaplan Fox is Investigating Potential Securities Law Violations Against The Ensign Group, Inc. (NASDAQ: ENSG)
Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations against The Ensign Group, Inc. (NASDAQ: ENSG) following a report by Hunterbrook Media alleging inadequate patient care and data misrepresentation. The report, titled "Ensign: The Nursing Home Empire Built On Fatal Neglect," claims Ensign's business model relies on delivering substandard care while manipulating quality data. Following the news, Ensign's stock price dropped by 8.15%, and Kaplan Fox is urging affected investors to come forward.
The Ensign Group Increases Credit Facility to $800 Million and Extends Maturity
The Ensign Group, Inc. has amended its revolving Credit Facility, increasing commitments to $800 million and extending the maturity date to August 19, 2031. This move enhances the company's liquidity and financial flexibility, supporting its growth strategy including acquisitions and capital investments. CEO Barry Port highlighted that the increased capacity reflects confidence in their operating model and financial strength, positioning them for continued value creation for stakeholders.
The Ensign Group, Inc. Increases Credit Facility to $800 Million and Extends Maturity
The Ensign Group, Inc. has increased its revolving credit facility by $200 million, bringing the total to $800 million, and extended its maturity to August 19, 2031. This amendment provides enhanced liquidity and financial flexibility for the company's growth strategies, including acquisitions and capital investments. The interest rates for the facility are variable, based on a base rate or Term SOFR, plus a margin determined by the company's debt to EBITDA ratio.
Is the Options Market Predicting a Spike inThe Ensign Group Stock?
The options market is indicating potential significant movement for The Ensign Group, Inc. (ENSG) stock, particularly highlighted by high implied volatility in the September 18, 2026 $140.00 Call. This suggests investors anticipate a big price swing, possibly due to an upcoming event. Analysts currently rate ENSG as a Zacks Rank #2 (Buy), with recent upward revisions to earnings estimates, further fueling interest in the stock's future performance.
The Ensign Group Increases Credit Facility to $800 Million and Extends Maturity
The Ensign Group, Inc. has increased its revolving Credit Facility to $800 million and extended its maturity date to August 19, 2031. This move aims to enhance liquidity and financial flexibility to support the company's growth strategy, including acquisitions and capital investments. The financing reflects strong confidence from lending partners in Ensign's operating model and disciplined growth.
Kaplan Fox is Investigating Potential Securities Law Violations Against The Ensign Group, Inc. (NASDAQ: ENSG)
Kaplan Fox & Kilsheimer LLP is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potential securities law violations. This follows a Hunterbrook Media report alleging that Ensign's business model involves inadequate patient care and manipulated quality data, leading to an 8.15% drop in Ensign's stock price. The law firm is seeking investors who suffered losses to join their investigation.
53,135 Shares in The Ensign Group, Inc. $ENSG Purchased by NewEdge Wealth LLC
NewEdge Wealth LLC acquired 53,135 shares of The Ensign Group, Inc. (NASDAQ:ENSG) valued at approximately $8,518,000 during the second quarter, representing about 0.09% of the company. Other institutional investors also adjusted their stakes, with BlackRock Inc. purchasing a significant new position. The article also details recent insider stock sales, The Ensign Group's financial performance, dividend announcement, and current analyst ratings.
Rosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG
The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG) following allegations of misleading business information. This investigation stems from a short seller report claiming Ensign's business model relies on inadequate patient care and manipulation of quality metrics, leading to an 8.15% drop in stock value on June 8, 2026. Investors who purchased Ensign securities are encouraged to contact the firm to join a prospective class action lawsuit seeking compensation for losses.
Rosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG
The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG) following allegations that the company issued misleading business information. This investigation comes after a short seller report claimed Ensign's business model relies on inadequate patient care and manipulating quality metrics, leading to an 8.15% stock drop on June 8, 2026. Investors who purchased Ensign securities are encouraged to contact the firm to learn about joining a prospective class action lawsuit.
Kaplan Fox Investigates The Ensign Group Over Alleged Securities Violations Following Stock Drop
Law firm Kaplan Fox & Kilsheimer LLP has launched an investigation into The Ensign Group, Inc. (NASDAQ: ENSG) concerning potential securities violations. This probe follows a report by Hunterbrook Media on June 8, 2026, which alleged inadequate patient care and systematic data misrepresentation at Ensign's nursing facilities. Following the report's publication, Ensign's stock price dropped significantly, leading Kaplan Fox to invite investors who incurred losses to come forward.
Kaplan Fox is Investigating The Ensign Group, Inc. (NASDAQ: ENSG) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm
Kaplan Fox & Kilsheimer LLP is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potential securities law violations following a report by Hunterbrook Media alleging the company's business model relies on inadequate patient care and manipulated quality data. Following this report, Ensign's stock price dropped significantly. Investors who suffered losses are encouraged to contact Kaplan Fox for more information regarding this investigation.
Rice Hall James & Associates LLC Buys Shares of 15,777 The Ensign Group, Inc. $ENSG
Rice Hall James & Associates LLC recently acquired 15,777 shares of The Ensign Group, Inc. (NASDAQ:ENSG) for approximately $2.53 million during the second quarter. Institutional investors hold a significant 96.12% stake in the company. Analysts have a "Moderate Buy" consensus rating with an average price target of $216.25, while the company reported strong Q2 earnings, surpassing estimates with EPS of $1.92 and a 16.7% increase in revenue year-over-year.
JLB & Associates Inc. Purchases Shares of 72,090 The Ensign Group, Inc. $ENSG
JLB & Associates Inc. has acquired 72,090 shares of The Ensign Group, Inc. (NASDAQ:ENSG), valued at approximately $11.6 million, making it 1.5% of their portfolio. This purchase comes as The Ensign Group exceeded its quarterly earnings expectations with an EPS of $1.92 and saw a 16.7% revenue increase year-over-year. The company maintains a "Moderate Buy" consensus rating from analysts with an average price target of $216.25.
2 Reasons to Like ENSG (and 1 Not So Much)
The Ensign Group (ENSG) has seen its stock price fall by 10.9% over the past six months, contrasting with the S&P 500's 12.9% climb. Despite this recent underperformance, the company shows strong long-term momentum with impressive compounded annual growth rates in both revenue (17.7%) and EPS (13.9%) over the last five years, outpacing most healthcare businesses. However, a concerning aspect is the 18.5% year-on-year decline in sales volumes over the past two years, suggesting potential market saturation or increased competition.
Kaplan Fox is Investigating The Ensign Group, Inc. (NASDAQ: ENSG) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm
Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations by The Ensign Group, Inc. (NASDAQ: ENSG) following a Hunterbrook Media report alleging "fatal neglect" and systematic misrepresentations in patient care. The report, published on June 8, 2026, caused Ensign's stock price to fall by 8.15%. Investors who suffered losses are encouraged to contact Kaplan Fox for more information regarding the investigation.
Kaplan Fox is Investigating The Ensign Group, Inc. (NASDAQ: ENSG) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm
Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations against The Ensign Group, Inc. (NASDAQ: ENSG) following a report by Hunterbrook Media titled "Ensign: The Nursing Home Empire Built On Fatal Neglect." The report alleges inadequate patient care and systematic misrepresentations, causing Ensign's stock to drop. Investors who suffered losses or have information are encouraged to contact Kaplan Fox.
The Ensign Group, Inc. (NASDAQ:ENSG) Given Average Recommendation of "Moderate Buy" by Brokerages
The Ensign Group, Inc. (NASDAQ:ENSG) has received an average "Moderate Buy" rating from brokerages, with an average 12-month price target of $216.25, suggesting potential upside from its current price of $181.65. The company recently reported strong quarterly results, beating earnings estimates with $1.92 per share and seeing revenue growth of 16.7% year-over-year. Institutional investors hold a substantial 96.12% of the shares, while some directors have sold shares under pre-arranged Rule 10b5-1 plans.
ABN AMRO Bank N.V. Takes $937,000 Position in The Ensign Group, Inc. $ENSG
ABN AMRO Bank N.V. has acquired a new position of 5,858 shares, valued at $937,000, in The Ensign Group, Inc. during the second quarter. This move comes as several other institutional investors have also adjusted their holdings in ENSG, with notable increases from Mitsubishi UFJ Trust & Banking Corp and Sanctuary Advisors LLC, and new stakes from NewEdge Wealth LLC and Norges Bank. The Ensign Group has received a "Moderate Buy" rating from analysts with a consensus target price of $216.25, and has also announced a quarterly dividend.
53,769 Shares in The Ensign Group, Inc. $ENSG Bought by Oppenheimer Asset Management Inc.
Oppenheimer Asset Management Inc. recently acquired 53,769 shares of The Ensign Group, Inc. (NASDAQ:ENSG), valued at approximately $8.6 million, making them a new institutional investor in the company. Other institutional investors collectively own 96.12% of ENSG. The Ensign Group reported strong Q2 earnings, beating estimates with $1.92 EPS and a 16.7% revenue increase, and has a positive "Moderate Buy" analyst consensus, despite some recent insider share sales.
Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm is investigating potential securities claims on behalf of investors who suffered losses in The Ensign Group, Inc. (NASDAQ: ENSG). This investigation follows a short seller report alleging Ensign's business model relies on inadequate patient care and manipulated quality metrics, leading to an 8.15% stock drop on June 8, 2026. The firm encourages affected investors to contact them to join a prospective class action.
Dockside LLC Buys Shares of 13,600 The Ensign Group, Inc. $ENSG
Dockside LLC recently acquired 13,600 shares of The Ensign Group, Inc. (NASDAQ:ENSG) valued at approximately $2.18 million during the second quarter. Other institutional investors have also adjusted their positions in the company, which reported strong quarterly earnings, beating estimates with an EPS of $1.92 and revenue of $1.44 billion, up 16.7% year-over-year. The Ensign Group has a "Moderate Buy" consensus rating from analysts, with an average price target of $216.25, despite some recent insider share sales.
Ensign Group Slides as Short-seller Report Sparks Investor Concern
Ensign Group's stock slid following the release of a short-seller report from Night Market Research. The report alleges that Ensign uses a "predatory business model" involving asset stripping, which has led to significant financial distress for some of its care facilities. Despite these claims, the company has shown strong financial performance and recent strategic expansions.
Ensign Group (ENSG) Stock Dropped 8.15% After Nursing Home Care Allegations; Law Firm Opens Securities Investigation
The Ensign Group, Inc. (NASDAQ: ENSG) is under investigation by Kaplan Fox & Kilsheimer LLP for potential violations of federal securities laws. This follows a report from Hunterbrook Media alleging systemic patient care failures and data manipulation within Ensign's nursing home operations, which caused ENSG stock to drop 8.15% on June 8, 2026. The law firm is seeking contact from investors who have suffered losses and individuals with relevant information regarding the allegations.
Ensign Group (ENSG) President & COO gifts 2,500 shares, retains 65,970
Ensign Group (ENSG) President and COO Burton Spencer gifted 2,500 shares of common stock on August 11, 2026, as reported in a Form 4 filing. This transaction was executed under a Rule 10b5-1 trading plan adopted on February 9, 2026. Following this gift, Spencer directly holds 65,970 shares of ENSG common stock.
Ensign Investor News: If You Have Suffered Losses in The
The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG) following allegations of misleading business information. This investigation stems from a short seller report claiming Ensign's business model relies on inadequate patient care and understaffing, leading to an 8.15% drop in Ensign Group's shares on June 8, 2026. Investors who purchased Ensign securities are encouraged to contact the firm to potentially join a class action lawsuit seeking to recover losses.
Ensign Group (ENSG) Stock Drops 8% After Hunterbrook Media Report as Law Firm Launches Securities Investigation
The Ensign Group (ENSG) saw its stock drop 8% after a Hunterbrook Media report alleged patient care deficiencies and manipulation of quality data in its nursing home operations. Following this, the law firm Kaplan Fox & Kilsheimer LLP launched an investigation into ENSG for potential securities law violations. Investors are advised to monitor developments related to Ensign's response and the ongoing investigation.
The Ensign Group, Inc. $ENSG is Wasatch Advisors LP's 2nd Largest Position
Wasatch Advisors LP has significantly increased its stake in The Ensign Group, Inc. (NASDAQ:ENSG), making it their second-largest holding, owning 3.90% of the company worth $365.2 million. Other institutional investors have also adjusted their positions in ENSG. The article also details recent insider stock sales, analyst ratings, ENSG's financial performance including its latest earnings beat, and its declared quarterly dividend.
The Ensign Group, Inc. (ENSG) Stock Analysis: Navigating a 20% Potential Upside Amid Strong Revenue Growth
The Ensign Group, Inc. (ENSG) presents a compelling investment opportunity with a potential upside of 20% due to strong revenue growth and positive analyst sentiment. Despite its stock being in overbought territory, the company demonstrates efficient management, profitability, and strategic expansion within the healthcare sector. Investors should, however, remain aware of regulatory risks and potential short-term overvaluation.
Bank of America Corp DE Has $70.11 Million Holdings in The Ensign Group, Inc. $ENSG
Bank of America Corp DE reduced its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 6.7% in the first quarter, now holding shares valued at $70.11 million. Despite this reduction, other institutional investors have increased their positions in ENSG. The Ensign Group recently reported strong quarterly earnings, beating analyst estimates, and has a consensus "Moderate Buy" rating from analysts.
Ensign Group (ENSG) Investor Alert: Investigation into Potential Fiduciary Duty Breaches - Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating whether officers and directors of The Ensign Group, Inc. (NASDAQ: ENSG) breached their fiduciary duties due to allegations of mismanagement and potential harm to the company and its shareholders. The investigation stems from a Muddy Waters Research report accusing Ensign of systematic fraud involving license renting for administrators in skilled nursing facilities, which could lead to billions in False Claims Act sanctions. Current shareholders are encouraged to contact the firm to learn about their potential legal rights.
Kaplan Fox Investigates The Ensign Group Over Alleged Securities Violations After Stock Drop
Kaplan Fox & Kilsheimer LLP has launched an investigation into The Ensign Group, Inc. (NASDAQ: ENSG) following a report by Hunterbrook Media alleging inadequate patient care and data misrepresentation. The Hunterbrook Media report, titled "Ensign: The Nursing Home Empire Built On Fatal Neglect," caused Ensign's stock to drop by 8.15% on June 8, 2026. Kaplan Fox is seeking investors who suffered losses or have relevant information to aid their investigation into potential securities law violations.
Ensign Group (ENSG) Investor Alert: Investigation into Potential Fiduciary Duty Breaches - Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potential breaches of fiduciary duties by its officers and directors. This investigation follows a Muddy Waters Research report alleging that Ensign Group engages in a systematic scheme at approximately 20% of its skilled nursing facilities by renting Administrator licenses from individuals not actively managing the facilities. The law firm is evaluating whether this practice constitutes fraud against state, Medicare, and Medicaid programs, potentially leading to billions in False Claims Act sanctions.
Royal Bank of Canada Sells 6,650 Shares of The Ensign Group, Inc. $ENSG
Royal Bank of Canada reduced its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 9.4% in the first quarter, selling 6,650 shares but still retaining 63,888 shares valued at approximately $12.9 million. Other institutional investors like Baillie Gifford & Co., Norges Bank, and Candriam S.C.A. either increased or initiated positions in the company. The Ensign Group reported strong Q1 earnings with EPS of $1.92, surpassing estimates, and a 16.7% year-over-year revenue increase to $1.44 billion, leading to a "Moderate Buy" consensus rating from analysts with an average price target of $216.25.
Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) following a short seller report alleging the company's business model relies on inadequate patient care and gaming quality metrics, causing its stock to fall. Investors who purchased Ensign securities are encouraged to contact the firm to join a prospective class action lawsuit seeking to recover losses. The firm highlights its experience and track record in securities class actions.
Kaplan Fox is Investigating The Ensign Group, Inc. (ENSG) for Potential Violations of the Federal Securities Laws
Kaplan Fox & Kilsheimer LLP is investigating The Ensign Group, Inc. (ENSG) for potential securities violations following a Hunterbrook Media report alleging inadequate patient care and data manipulation. The report, titled "Ensign: The Nursing Home Empire Built On Fatal Neglect," caused Ensign's stock to drop over 8% on June 8, 2026. Investors who suffered losses are encouraged to contact Kaplan Fox for more information regarding the investigation.
21,400 Shares in The Ensign Group, Inc. $ENSG Bought by Renaissance Technologies LLC
Renaissance Technologies LLC acquired a new stake of 21,400 shares in The Ensign Group, Inc. (ENSG) during the first quarter, valued at approximately $4.3 million. This purchase contributes to the 96.12% institutional ownership of ENSG, although some directors recently sold shares under pre-arranged plans. The Ensign Group reported strong Q1 earnings, beating estimates with $1.92 EPS and 16.7% revenue growth, and analysts maintain a "Moderate Buy" rating with an average price target of $216.25.
Kaplan Fox Encourages Investors of The Ensign Group, Inc. (NASDAQ: ENSG) to Contact the Firm Regarding an Investigation Into Possible Securities Law Violations
Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations by The Ensign Group, Inc. (NASDAQ: ENSG) following a report from Hunterbrook Media alleging that Ensign's business model relies on inadequate patient care and systematic misrepresentations. This news led to an 8.15% drop in Ensign's stock price. The law firm is encouraging investors who have suffered losses to contact them for more information regarding the investigation.
Ensign Group (ENSG) Shareholder Alert: Investigation into Potential Fiduciary Duty Breaches - Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating Ensign Group (NASDAQ: ENSG) regarding potential breaches of fiduciary duties by its officers and directors, and whether the company and its shareholders may have been harmed. This investigation follows a report by short seller Muddy Waters Research, which alleged that Ensign engages in a systematic scheme of renting Administrator licenses at approximately 20% of its skilled nursing facilities, potentially amounting to fraud against states, Medicare, and Medicaid. Shareholders are encouraged to contact the firm to learn more about their potential legal rights.
Should Ensign Group’s (ENSG) Higher 2026 Earnings Guidance Prompt Action From Investors?
The Ensign Group (ENSG) reported strong Q2 2026 results with higher revenue and net income, leading to an increased full-year 2026 earnings guidance of US$7.75–US$7.85 per diluted share on US$5.87–US$5.92 billion in revenue. This upgraded outlook, driven by their "roll up" model of acquiring and improving skilled nursing and senior care facilities, suggests management's increased confidence in future growth. Investors should consider how this guidance reinforces the company's investment narrative but also raises expectations and potential risks related to acquisition integration, occupancy, and cost control.
Ensign Group (ENSG) Shareholder Alert: Investigation into Potential Fiduciary Duty Breaches - Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potential breaches of fiduciary duties by its officers and directors. The investigation stems from allegations in a Muddy Waters Research report claiming Ensign engages in a systematic scheme involving renting administrator licenses for skilled nursing facilities, which could amount to fraud against Medicare and Medicaid. Ensign Group shareholders are encouraged to contact the firm to learn more about their potential legal rights.
Ensign Investor News: If You Have Suffered Losses in The Ensign Group, Inc. (NASDAQ: ENSG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG) after a short seller report alleged the company's business model relies on inadequate patient care and understaffing, leading to an 8.15% drop in share price on June 8, 2026. Investors who purchased Ensign securities are encouraged to contact the firm to join a prospective class action lawsuit seeking recovery of losses. The firm emphasizes its track record in securities class actions, having recovered billions for investors.
Kaplan Fox Announces an Investigation Into The Ensign Group, Inc. (NASDAQ: ENSG) for Potential Securities Law Violations
Kaplan Fox & Kilsheimer LLP has launched an investigation into The Ensign Group, Inc. (NASDAQ: ENSG) following allegations of securities law violations. A report by Hunterbrook Media accused Ensign of delivering inadequate patient care and manipulating quality data, leading to an 8.15% drop in the company's stock price on June 8, 2026. The law firm is seeking investors who suffered losses or have information related to the investigation.
Lowey Dannenberg, P.C. is Investigating The Ensign Group
Lowey Dannenberg, P.C. is investigating The Ensign Group (NASDAQ: ENSG) for potential violations of federal securities laws after two short-seller reports. Hunterbrook alleged systemic quality-measure gaming and falsified data, while Muddy Waters Research claimed possible Medicare and Medicaid fraud through improper administrator licensing. These allegations led to significant drops in Ensign's stock price and substantial shareholder losses.
The Ensign Group, Inc. (ENSG): Investor Outlook With A 23.48% Potential Upside
The Ensign Group, Inc. (ENSG) presents an appealing investment opportunity with a potential upside of 23.48%, supported by strong analyst buy ratings and robust financial performance, including 17.30% revenue growth and $280.6 million in free cash flow. Despite some valuation metrics needing closer scrutiny and an overbought RSI, the company's strategic growth, diverse operational model, and focus on reinvestment suggest a compelling case for investors. Ensign's ability to adapt and expand its specialized healthcare services will be key to realizing its future growth potential.
Rosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG
Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG) following a short seller report alleging inadequate patient care and misleading business practices. The report by Hunterbrook claimed Ensign's profits rely on understaffing facilities and diverting taxpayer money, which led to an 8.15% drop in Ensign's stock on June 8, 2026. The firm is preparing a class action lawsuit to recover investor losses and is encouraging affected shareholders to join.
Rosen Law Firm Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSG
The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. (NASDAQ: ENSG) following a short seller report alleging the company's business model relies on inadequate patient care and gaming quality metrics, leading to patient harm and death. Investors who purchased Ensign securities are encouraged to inquire about joining a prospective class action to recover losses. The firm emphasizes its track record in securities class action litigation.
Vanguard Portfolio Management (ENSG) discloses 2.87M-share beneficial stake in The Ensign Group
Vanguard Portfolio Management LLC has disclosed a beneficial ownership of 2.87 million shares, representing a 4.91% stake, in The Ensign Group, Inc. This information was reported in an amended Schedule 13G filing. Vanguard holds sole voting power over 6,641 shares and sole dispositive power over all 2,873,200 shares.
Enterprise value to EBITDA forward of The Ensign Group, Inc. – NASDAQ:ENSG
This article provides financial data for The Ensign Group, Inc. (NASDAQ: ENSG), specifically focusing on its enterprise value to EBITDA forward metric. It appears to be a data page from TradingView, displaying key financial information for investors. The content confirms the market status and notes that the data is provided by ICE Data Services and FactSet.
